Eagle Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-337,609
| Closed | -$9.06M | – | 613 |
|
|
2022
Q1 | $9.06M | Sell |
337,609
-29,228
| -8% | -$785K | 0.05% | 287 |
|
|
2021
Q4 | $17.8M | Sell |
366,837
-30,665
| -8% | -$1.49M | 0.08% | 226 |
|
|
2021
Q3 | $26.4M | Sell |
397,502
-32,798
| -8% | -$2.18M | 0.12% | 195 |
|
|
2021
Q2 | $33.6M | Buy |
430,300
+4,427
| +1% | +$345K | 0.14% | 188 |
|
|
2021
Q1 | $38.6M | Buy |
425,873
+43,462
| +11% | +$3.94M | 0.17% | 184 |
|
|
2020
Q4 | $46.6M | Sell |
382,411
-57,412
| -13% | -$7M | 0.26% | 141 |
|
|
2020
Q3 | $38.9M | Sell |
439,823
-2,891
| -0.7% | -$256K | 0.2% | 170 |
|
|
2020
Q2 | $28.3M | Buy |
442,714
+329,307
| +290% | +$21.1M | 0.16% | 187 |
|
|
2020
Q1 | $5.06M | Buy |
+113,407
| New | +$5.06M | 0.03% | 361 |
|